Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects

Fig. 1

Study design. IND/GLY/MF is a combination of indacaterol acetate 150 μg, glycopyrronium bromide 50 μg and mometasone furoate 80 μg. (medium-dose ICS) or 160 μg (high-dose ICS) delivered o.d. via the Breezhaler®. GLY glycopyrronium bromide, IND indacaterol acetate, MF mometasone furoate, o.d. once daily

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us